<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="103">
  <stage>Registered</stage>
  <submitdate>1/08/2005</submitdate>
  <approvaldate>5/08/2005</approvaldate>
  <actrnumber>ACTRN12605000074695</actrnumber>
  <trial_identification>
    <studytitle>Does a 24% sucrose solution (used for procedural pain relief) have similar analgesic properties when given to infants of substance abusing mothers, compared to matched healthy infants</studytitle>
    <scientifictitle>Does a 24% sucrose solution (used for procedural pain relief) have similar analgesic properties when given to infants of substance abusing mothers, compared to matched healthy infants</scientifictitle>
    <utrn />
    <trialacronym>Does sucrose act differently i</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Procedural pain</healthcondition>
    <conditioncode>
      <conditioncode1>Alternative and complementary medicine</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The aim of this study is to show that sucrose has a similar analgesic effect, when given to an infant born to a substance dependent mother, compared to a healthy matched infant. The secondary aim of this study is to objectively assess the effectiveness of sucrose with a modified pain assessment tool. 
Prospective cohort study. 26 healthy term infants (control) vs 26 Infants of substance abuse mothers. 
Compare the two groups response to a "heel stick" blood sample for the NSW Newborn Screening test, when both groups have been given 0.05ml of a 24 % sucrose solution (orally) throughout the procedure every 1-2 minutes.</interventions>
    <comparator />
    <control />
    <interventioncode>None</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Modified pain assessment tool, that rates a pain response on assessment of the infants facial expression, body movement and oxygen saturation and heart rate.</outcome>
      <timepoint>Measurements at 2 minutes before the heelstick (baseline), during the heel stick and 2 minutes after the heelstick.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>There is no further monitoring required after the completion of the study.</outcome>
      <timepoint />
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Written infarmed consent for the NSW Newborn screening test as well as the research study. All infants must be greater than 37 weeks completed gestation.</inclusivecriteria>
    <inclusiveminage>37</inclusiveminage>
    <inclusiveminagetype>Weeks</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Symptoms of respiratory distress, problems with glucose metabolism, feed intolerance or necrotising entero-colitis, congenital anomalies, grade three or grade four intraventricular haemorrhages.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Screening</purposeobs>
    <duration>Longitudinal</duration>
    <selection>Case control</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>2/07/2005</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>56</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>James Rodney Marceau</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>NIL</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Sucrose when given to newborn infants has analgesic properties, especially when used for the relief of procedural pain. The calming effects of the sweet taste, cause the release of naturally occuring endorphins (morphine- like substances). The aim of this study is to show that sucrose has the same pain relieving effects in the infant of a substance dependent mother, compared to healthy (matched) infant.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Sydney West Area Health Service</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Human Research Ethics Committee</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>James Rodney Marceau</name>
      <address>30 Glenell St
Blaxland NSW 2774</address>
      <phone>+61 2 47392303</phone>
      <fax />
      <email>marceau@aapt.net.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>James Rodney Marceau</name>
      <address>30 Glenell St
Blaxland NSW 2774</address>
      <phone>+61 2 47392303</phone>
      <fax />
      <email>marceau@aapt.net.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>